PTSD

During the ongoing conflict between Israel and Hamas, Israel's Ministry of Health reported a significant increase in its medical marijuana program. In October, patient enrollment in the medical cannabis registry increased by 2,202 individuals, double the average monthly growth....

In the evolving narrative of modern medicine, there's a new chapter being written by the pioneers at the helm of Mystic Ventures, where managing partner Jeremy Gardner is intently focused on the profound potential of psychedelics. The latest developments in this arena are not just about a...

California Gov. Gavin Newsom (D) vetoed a bill on Saturday that would have decriminalized the possession and personal use of certain hallucinogens, including psychedelic mushrooms. The bill would not have legalized the sale of these substances, but rather sought to ensure that individuals were...

Ukraine's health ministry recently confirmed that some 57% of Ukrainians are at risk of developing PTSD due to the now 20-month-long war with Russia. Despite research that cannabis can help treat PTSD symptoms, it is not available yet for medical research or treatment in Ukraine, though it has...

Hemp Box ETC founder and CEO Sandy Moore spoke at the recent Benzinga Cannabis Capital Conference in Miami about helping fellow veterans cope with post-traumatic stress disorder (PTSD).  "I feel that the connection with veterans is that we all have that similar trauma as...

In an urgent appeal to rethink current medical marijuana policies, Rep. Earl Blumenauer (D-OR), has criticized the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) for their "misguided denial of services." The Democratic congressman's concerns stem from both...

As debates around potential post-traumatic stress disorder (PTSD) treatments continue, the use of cannabis and its derivatives has come under increased scrutiny. Despite claims of effectiveness, key stakeholders such as the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD)...

This article was originally published on Psychedelic Spotlight and appears here with permission. Australia’s approval of MDMA and psilocybin-assisted therapy may be what the U.S. regulators need to expedite the approval process in the States. On Saturday, July 1, 2023, Australia officially...

The Massachusetts Cannabis Control Commission (CCC) is actively reviewing potential changes to enhance veterans' access to medical marijuana. The proposed rules aim to address the barriers faced by veterans who are currently unable to benefit fully from the medical marijuana...

Members of Congress are set to consider a measure that would streamline research into medical cannabis use for military veterans, reported Marijuana Moment. The Veterans Cannabis Analysis, Research and Effectiveness (CARE) Act was reintroduced last week by Rep. Mariannette Miller-Meeks (R...

Cannabis company Creso Pharma (OTCMKTS: COPHF)’s wholly-owned psychedelics subsidiary Halucenex Life Sciences Inc. shared promising early findings on its ongoing Phase 2 clinical trial assessing the efficacy of psilocybin on treatment-resistant PTSD.  The single-arm, open-lab study tests...

Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction. Accelerating Research At a...

The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following the approval of a joint application submitted by MAPS PBC and COMPASS Pathways (NASDAQ: CMPS). On March 3, the AMA published its Panel Actions summary which included the...

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) is advancing the development of its novel compounds family of next-gen MDMA analogs. So far, Mydecine's compounds show promising pharmacokinetics (PK) and pharmacodynamics (PD) in preclinical models.  The new data on the MYCO-006...

Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine. Among the attendees was Enveric Biosciences Inc (NASDAQ: ENVB) CEO Dr. Joseph Tucker, who shared some...